EDBI Logo
|  
Flyout Menu

EDBI 2020 Q1 – Q1 2020

EDBI 2020 Q1 – Q1 2020

Related Posts

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

  • 05 03 2025
  • |
Read More

Portfolio Spotlight Ep 5: Endowus with Co-Founder, Chairman and Group CIO, Samuel Rhee

  • 20 02 2025
  • |
Read More

Island Announces Participation of Singapore-based Global Investor EDBI in its Series D Round to Accelerate Expansion Plans in the Asia-Pacific Region

  • 11 12 2024
  • |
Read More

Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders

  • 16 10 2024
  • |
Read More

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore

  • 02 10 2024
  • |
Read More

The Upside – EDBI E-Newsletter 2024 Sep

  • 17 09 2024
  • |
Read More

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now

Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.

About EDBI

Team

Portfolio

News and Insights

Careers

Contact Us

Linkedin Youtube

© 2025 EDBI. All rights reserved.